Kiromic BioPharma Inc.

AI Score

0

Unlock

1.65
-0.01 (-0.75%)
At close: Feb 10, 2025, 1:13 PM
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
undefined%
Bid n/a
Market Cap 2.53M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -6.22
PE Ratio (ttm) -0.27
Forward PE n/a
Analyst n/a
Ask n/a
Volume 100
Avg. Volume (20D) 1,713
Open 1.65
Previous Close 1.66
Day's Range 1.65 - 1.65
52-Week Range 0.75 - 3.78
Beta undefined

About KRBP

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candi...

Industry Biotechnology
Sector Healthcare
IPO Date Oct 16, 2020
Employees 35
Stock Exchange NASDAQ
Ticker Symbol KRBP